The burgeoning landscape of treatment for obesity and type 2 glucose intolerance is currently witnessing considerable excitement surrounding both retatrutide and tirzepatide. While both represent novel dual GIP and https://keiransulx433389.shoutmyblog.com/37763001/retatrutide-vs-tirzepatide-a-comparative-analysis